BioWorld

BioWorld

BioWorld Today provides valuable insights into groundbreaking drug development that fuels the healthcare industry and helps combat diseases. With a team of writers and editors located worldwide, BioWorld Today covers the latest news and offers essential viewpoints on numerous medicines in the pipeline, the companies developing these treatments, the business deals shaping the industry, and the regulatory challenges that both hinder and protect the process.

International, Trade/B2B
English
Online/Digital

Outlet metrics

Domain Authority
59
Ranking

Global

#267999

China

#24162

Category

N/A

Traffic sources
Monthly visitors

Articles

  • 2 days ago | bioworld.com | Shani Alexander

    Baxter brings room temperature surgical patch to EuropeBaxter International Inc. recently launched in Europe a new version of its surgical patch, the Hemopatch Sealing Hemostat, which can be stored at room temperature. The improved Hemopatch device eliminates the need for refrigeration, allowing surgeons to have the product on hand to quickly control bleeding or prevent leakage during surgery. BioWorld MedTech

  • 3 days ago | bioworld.com | Mari Serebrov

    Makary’s vision for slimmed-down US FDA somewhat reassuringNearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s taking first steps to implement his agenda. BioWorld BioWorld MedTech Regulatory U.S. FDA Policy

  • 1 week ago | bioworld.com | Mari Serebrov

    Budget woes ahead for US life sciences sector? The next major shock wave to hit the U.S. biopharma and med-tech industries could be the fiscal 2026 federal budget. Nearly one-third of the discretionary budget for the Department of Health and Human Services (HHS) could be wiped out, according to the White House Office of Management and Budget’s “pre-decisional” budget proposal, or passback, for HHS. BioWorld BioWorld MedTech Regulatory U.S. FDA NIH Policy

  • 1 week ago | bioworld.com | Mark McCarty

    NICE OKs conditional coverage of robotic surgeryThe U.K. National Institute for Health and Care Excellence (NICE) gave the nod to a total of 11 robotic surgical systems for use in the U.K.’s trusts, but this is no free pass as the agency expects the manufacturers of these systems to gather data under this conditional coverage framework. BioWorld MedTech Regulatory Europe NICE

  • 1 week ago | bioworld.com | Nuala Moran

    Home » Brink’s recombinase enzymes offer new gene editing approachBrink’s recombinase enzymes offer new gene editing approachNewco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes. BioWorld Financings Newco news Cancer CAR T Seed Europe

Contact details

Address

123 Example Street

City, Country 12345

Email Patterns

Socials

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Traffic locations